SageTech Medical

Animal Health Angels, a group of veterinary and animal health professionals committed to advancing innovation in the animal health industry, is proud to announce their strategic investment in SageTech Medical as part of an ambitious £650,000 seed round led by EMV Capital. This investment supports SageTech Medical’s pioneering work in developing sustainable solutions for anaesthetic gas capture and recycling—a breakthrough with implications for both human and animal healthcare.

SageTech Medical is at the forefront of innovative technology aimed at tackling environmental challenges associated with anaesthetic gas emissions. Their state-of-the-art systems capture and recycle these gases, significantly reducing greenhouse gas emissions from operating rooms. With this transformative approach, SageTech Medical not only supports eco-friendly practices but also contributes to cost efficiency within healthcare facilities.

95% of anaesthetic gases administered to a patient during a general anaesthetic go unused and are therefore vented away from the operating theatre for safety reasons. The anaesthetics are classified as F-Gases and are very damaging to the environment, warming the planet several hundred times more than carbon dioxide. In addition, their manufacture is very polluting. By capturing, purifying and reusing these gases in healthcare, the manufacture of virgin anaesthetic can be significantly reduced, with the associated reduction in climate impact.  This novel technology will replace rudimentary and flawed solutions currently used in some veterinary clinics that can lead to potentially harmful levels of waste anaesthetic gases in the working environment.

Wendy Furness MRCVS, co-founder of Animal Health Angels, says: “SageTech Medical’s mission aligns perfectly with our vision of fostering groundbreaking innovations that benefit the wider animal health ecosystem. Their commitment to sustainability and environmental stewardship is inspiring, and we are thrilled to play a role in their growth journey.”

Jamie Crittall MRCVS, co-founder of Animal Health Angels, added: “This investment marks a pivotal step for us as we support initiatives that enhance the future of veterinary and human healthcare alike. SageTech Medical’s technology exemplifies the type of forward-thinking solutions that will shape a more sustainable world for generations to come.”

Iain Menneer, CEO of SageTech Medical, shared his enthusiasm for the new partnership: “We are excited and grateful for the investment from Animal Health Angels, whose expertise and support will be invaluable as we scale our operations. Our innovative technology promises to revolutionize the way anaesthetic gases are managed, significantly lowering carbon footprints while ensuring the highest standards of care. The endorsement from such a well-regarded group in the animal health sector is a strong vote of confidence in our work.”

SageTech has carried out significant useability pilots with two major veterinary groups, resulting in exceptional user feedback.  The £650,000 seed round will allow SageTech Medical to advance its research and development, initiate wider rollout to veterinary practices across the UK and start preparations for entry into the European market.